Forbes -
16 May 2016 20:59
In trading on Monday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 3.9% on the day. Components of that ETF showing particular strength include shares of Anacor Pharmaceuticals (ANAC), up about 56.2% and shares of Synergy Pharmaceuticals (SGYP), up about 10.9% on the day.
Share this Article
Comment on this Article
Please to comment